ArticleCureus2025
A Rare Case of Hepatic Artery Vasospasm in a Native Liver.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic artery vasospasm (HAV) is a relatively uncommon vascular phenomenon that can arise after liver transplants. Its occurrence in a native liver presents an atypical clinical picture. There is a lack of sufficient data on its etiology, incidence, diagnostics and management leaving room for further investigation. This report presents a rare case of HAV in a 40-year-old woman with a native liver. A recent hip fall led to her admission, followed by markedly elevated liver enzymes one week later. Doppler ultrasound (US) revealed patent hepatic vasculature with an elevated resistivity index, which supported our presumed diagnosis. Because of limited data on preventative management for this diagnosis, we used the management of vasospastic angina to start a treatment course, which included a calcium channel blocker and a Statin. Her liver enzymes began to normalize, indicating a favorable response to treatment, ultimately leading to discharge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.